AEZS-120

N/A

Report date: 2025/01/26 19:08:52

Base Information

Drug NameAEZS-120
Drug Alias Namebacterial vector cancer vaccine (University of Wurzburg/Aeterna Zentaris)prostate cancer vaccine (Socium)AEZS-120
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Development/production technology > Recombinant vector vaccineBiologics > Protein drugs > Toxin +[4] 
Mechanisms of ActionProstate-specific antigen modulators
TargetsProstate-specific antigen
Therapy Area/IndicationsProstatic NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital of Wurzburg
China Registration ClassN/A

Develop Information

Active CompaniesSocium Therapeutics Inc
Inactive CompaniesUniversity Hospital of WurzburgCOSCIENS Biopharma Inc
Active IndicationsProstatic Neoplasms
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A